摘要
瑞芬太尼是目前临床使用的作用时间最短的μ阿片镇痛药,但临床应用中不少临床麻醉医师发现瑞芬太尼停药后可能出现痛觉超敏的现象。超敏有多种机制参与,涉及体内阿片类物质的平衡,NMDA通路的调控,α肾上腺受体的调控等。对超敏的防治方法,主要有中长效阿片药物,及选用氯胺酮、陆马多、奈福泮、加巴喷汀等非阿片类药物治疗。
Remifentanil, the shortest on-time and off-time μ opioid receptor analgesic, is found to produce hyperanalgesia after termination of administration. Many mechanisms, such as opioid balance, NMDA pathway control, a-receptor modification are involved in hyperanalgesia. Middle-and long-acting opioids, ketamine, tramadol, nefopam, gabapentin are useful to treat hy-peranalgesia.
出处
《国际麻醉学与复苏杂志》
CAS
2009年第2期177-180,共4页
International Journal of Anesthesiology and Resuscitation